Side-by-side comparison of AI visibility scores, market position, and capabilities
Bootstrapped; $550-1,250/month pricing; 23% annual revenue growth 2021; 210% activity increase; founded 1999; cloud-based construction planning leader
Touchplan is a lean construction planning and scheduling platform founded in 1999 that digitizes the Last Planner System methodology — a collaborative, commitment-based scheduling framework developed by construction management researchers Glenn Ballard and Greg Howell. The company was built on the premise that traditional Gantt-chart-based scheduling produces plans that diverge from reality almost immediately on active construction sites, and that reliable workflow requires frontline foremen and trade partners to make and track explicit weekly work commitments. Touchplan translates these analog planning practices — which relied on sticky notes on whiteboards — into a cloud-based collaborative environment accessible from any device on or off the jobsite.\n\nTouchplan's platform enables general contractors and owners to run pull planning sessions, manage lookahead schedules, track percent plan complete (PPC) metrics, and analyze constraint removal across all trades on a project. The software integrates with project management platforms including Procore and supports multi-stakeholder collaboration without requiring all participants to maintain separate licensed accounts. Pricing ranges from $550 to $1,250 per month per project, positioning Touchplan as accessible for mid-size commercial contractors without the enterprise overhead of full project controls software.\n\nTouchplan has grown steadily on a bootstrapped basis, reporting 23% annual revenue growth and a 210% increase in platform activity year over year — metrics that reflect organic expansion within the lean construction community rather than venture-backed growth marketing. The company has built a loyal user base among contractors who have adopted Last Planner as a standard operating methodology, and it benefits from the growing recognition that collaborative planning reduces rework and schedule overruns on complex commercial and industrial projects. Touchplan competes in a niche where its methodology-first positioning differentiates it from broader construction management platforms.
Denver healthcare REIT (NYSE: DOC) $21B combined; Healthpeak + Physicians Realty Trust merger Mar 2024, life science labs (SF/SD/Boston) + 300+ MOBs, competing with Alexandria Real Estate and Ventas.
Healthpeak Properties, Inc. is a Denver, Colorado-based healthcare real estate investment trust — publicly traded on the New York Stock Exchange (NYSE: DOC) as an S&P 500 Real Estate component — owning, operating, and developing healthcare-focused real estate including life science laboratory buildings (biopharmaceutical R&D facilities in South San Francisco, San Diego, Boston), medical office buildings (outpatient care facilities adjacent to major hospital campuses), and continuing care retirement communities through approximately 400 employees. In March 2024, Healthpeak Properties (then trading as HCP/PEAK) completed its $21 billion merger of equals with Physicians Realty Trust (DOC — medical office REIT with 300+ medical outpatient buildings in 30+ states) — adopting Physicians Realty Trust's ticker symbol "DOC" and creating a $21 billion combined healthcare REIT with 60+ million square feet of life science labs, 18+ million square feet of medical office, and the most diversified healthcare real estate portfolio among public healthcare REITs. CEO Scott Brinker leads the combined company's strategy of capitalizing on the structural demand drivers for healthcare real estate: life science lab demand driven by NIH funding, private biopharma venture investment, and drug approval tailwinds — and medical office demand driven by the shift of healthcare delivery from hospital inpatient settings to outpatient ambulatory care facilities that require real estate closer to patient populations. Healthpeak's life science portfolio in the three dominant biotech clusters (San Francisco Bay Area, San Diego's Torrey Pines/UTC corridor, Boston's Kendall Square/Route 128 corridor) positions it in the markets where biopharma and biotech tenants require Class A laboratory space for drug discovery and development.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.